Portfolio Company Operations & Exit

The previous chapter covered how value gets created. This chapter covers the operating relationship between a PE firm and its portfolio company during the hold, and the real decision at the end: how and when to exit.

The 100-day plan — front-loading the value creation agenda

Immediately post-close, PE firms and portfolio company management typically build a detailed 100-day plan — a prioritized set of initial actions across the value-creation levers from the previous chapter, deliberately front-loaded because the operational and organizational disruption of new ownership is already happening in that period regardless, making it the lowest-relative-cost window to also drive real, faster change.

Board governance during the hold

Unlike a public company board (Finance 101's deal-defense deep dive covered board mechanics in that context), a PE-owned company's board is typically dominated by the PE firm's own deal team, meeting far more frequently than a typical public company board and engaging much more directly in operational decisions — a genuinely more hands-on governance model than public-market investors, even active ones, typically have with the companies they own shares in.

Exit routes — how a PE fund actually realizes its return

• Strategic sale: selling to a corporate acquirer (the IBD track's entire M&A process, from the buyer's side) — often commands the highest price when a strategic buyer can capture real synergies (Finance 101's synergy-value math) that a purely financial buyer can't.
• Sponsor-to-sponsor sale: selling to another PE firm — genuinely common, and not necessarily a sign the business has been "milked out," despite that being a common misconception; it can reflect the selling fund's own capital return timeline (funds have finite lives) rather than the business having no further growth potential.
• IPO: taking the portfolio company public (the ECM track's entire process) — typically reserved for larger, more mature portfolio companies, and usually doesn't return 100% of the fund's position immediately, since a lock-up period (similar in concept to a hedge fund's own lock-up, from the Hedge Funds track) typically restricts selling all shares right at the IPO.

Worked example: comparing exit routes on the same company

A portfolio company has $60M of EBITDA. A strategic buyer, able to capture real synergies, offers 11x EBITDA = $660M. A sponsor-to-sponsor buyer, without those synergies, offers 9x EBITDA = $540M. The $120M difference is a direct, real illustration of Finance 101's IBD synergy-value logic from the buyer's side — a strategic acquirer can rationally justify paying more because the asset is genuinely worth more to them specifically, integrated into their existing business, than it's worth as a standalone entity to a financial buyer with no operational synergies to capture.

Why the exit decision is a genuinely strategic one, not just a return-maximizing formula

A PE firm choosing between exit routes weighs more than just headline price: certainty of close and timeline (a strategic sale can face real regulatory risk, per Finance 101's antitrust concepts, that a sponsor-to-sponsor deal often doesn't), the portfolio company's readiness for public-market scrutiny and reporting requirements if considering an IPO, and the fund's own capital-return timeline and its limited partners' expectations — the same multi-factor weighing the IBD track's pitch-book chapter described for a sell-side process, now applied specifically from a financial sponsor's seat.